Get FREE SHIPPING when you spend $99 or more | ATOMFAIR

Awaiting product image

Atomfair Resiquimod R-848 C17H22N4O2 CAS 144875-48-9

Resiquimod (CAS No. 144875-48-9) is a high-purity synthetic imidazoquinoline compound with the molecular formula C17H22N4O2. This small molecule immunostimulant is chemically designated as 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol and is provided as a white to off-white crystalline powder. Resiquimod is a potent Toll-like receptor (TLR) 7 and TLR8 agonist known for its ability to induce cytokine production, particularly interferon-alpha, making it valuable for immunological research. Our product is rigorously tested by HPLC and NMR to ensure >98% purity, with batch-specific certificates of analysis available. Suitable for in vitro and in vivo studies, this compound is provided in amber vials under inert atmosphere to ensure…

Category:

Description

Resiquimod (CAS No. 144875-48-9) is a high-purity synthetic imidazoquinoline compound with the molecular formula C17H22N4O2. This small molecule immunostimulant is chemically designated as 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol and is provided as a white to off-white crystalline powder. Resiquimod is a potent Toll-like receptor (TLR) 7 and TLR8 agonist known for its ability to induce cytokine production, particularly interferon-alpha, making it valuable for immunological research. Our product is rigorously tested by HPLC and NMR to ensure >98% purity, with batch-specific certificates of analysis available. Suitable for in vitro and in vivo studies, this compound is provided in amber vials under inert atmosphere to ensure stability. Store at -20°C protected from light and moisture.

Properties

  • CAS Number: 144875-48-9
  • Complexity: 406
  • IUPAC Name: 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methyl-propan-2-ol
  • InChI: InChI=1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19)
  • InChI Key: BXNMTOQRYBFHNZ-UHFFFAOYSA-N
  • Exact Mass: 314.17427596
  • Molecular Formula: C17H22N4O2
  • Molecular Weight: 314.4
  • SMILES: CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
  • Topological: 86.2
  • Monoisotopic Mass: 314.17427596
  • Synonyms: Resiquimod, 144875-48-9, 1-(4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol, Resiquimod [INN], R 848, 1-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol, UNII-V3DMU7PVXF, V3DMU7PVXF, S 28463, CHEBI:36706, RESIQUIMOD [MI], RESIQUIMOD [USAN], RESIQUIMOD [MART.], CD11301, RESIQUIMOD [WHO-DD], CD-11301, 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-, DTXSID7040603, RESIQUIMOD (MART.), 4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol, 1H-Imidazo(4,5-c)quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-, 4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol, resiquimodum, 1-(4-amino-2-(ethoxymethyl)-1H-imidazo(4,5-c)quinolin-1-yl)-2-methylpropan-2-ol, 1H-Imidazo(4,5-c)quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-I+-,I+–dimethyl-, 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-I+-,I+–dimethyl-, 4-Amino-2-(ethoxymethyl)-I+-,I+–dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol, 4-Amino-2-(ethoxymethyl)-I+-,I+–dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, DTXCID5020603, R-848, R848, S-28463, MFCD00937759, Resiquimod (GMP), 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol, CHEMBL383322, R848;S28463, alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol, 1-(4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol., R848 compound, VML-600, ResiquimodR848?, RX8, R848; Resiquimod, SCHEMBL34159, MLS006010212, GTPL5051, Resiquimod, >=98% (HPLC), 4-Amino-2-(ethoxymethyl)-alpha, BXNMTOQRYBFHNZ-UHFFFAOYSA-N, GLXC-06608, HMS3740O09, HMS5086I07, BCP09103, EX-A1879, BDBM50241029, HY-13740G, NSC828390, s8133, AKOS016003509, CCG-267635, CS-1706, DB06530, NSC-828390, SB17111, 1-(4-Amino-2-ethoxymethyl-imidazo[4,5-c]quinolin-1-yl)-2-methyl-propan-2-ol, s28463, NCGC00370784-01, NCGC00370784-05, AC-35716, AS-30885, FR170507, HY-13740, SMR002530531, SY107476, CS-0645881, NS00071828, R0197, Q426054, SR-01000944954, SR-01000944954-1, BRD-K76210423-001-01-6, BRD-K76210423-001-02-4, 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methyl-propan-2-ol, 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-|A,|A-dimethyl-, 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1H-imidazo[4,5-c]quinolin-1-ethanol, 4-Amino-alpha,alpha-dimethyl-2-ethoxymethyl-1H-imidazo[4,5-c]quinoline-1-ethanol

Application

Resiquimod is widely used as a research tool for studying innate immune responses through its action as a dual TLR7/TLR8 agonist. The compound has shown utility in preclinical studies of antiviral therapies, cancer immunotherapy, and vaccine adjuvants. Researchers employ Resiquimod to investigate cytokine induction pathways, particularly interferon-mediated antiviral defenses. Its ability to stimulate dendritic cell maturation makes it valuable for immunological studies. Recent applications include exploration of topical formulations for dermatological conditions.

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.

Disclaimer

Intended Use & Restrictions

This product is sold exclusively for laboratory research, analytical testing, or non-commercial purposes.

  • Strictly prohibited: Resale, repackaging, or formulation into commercial products.
  • Not approved for human/animal use, diagnostics, or manufacturing (including pharmaceuticals, agrochemicals, or consumer goods).

Patent & Regulatory Compliance

Certain molecules may be protected by active patents or regulatory restrictions.

  • Buyers must independently verify patent status (e.g., via USPTO/EPO/CNIPA) and comply with local laws.
  • Atomfair LLC does not provide legal assurances regarding patent non-infringement or jurisdictional compliance.

Liability Release

By purchasing, the buyer agrees to:

  • Use this product only as permitted by law.
  • Indemnify Atomfair LLC against all claims arising from misuse, patent infringement, or regulatory violations.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products